Imatinib Mesylate
3 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Imatinib Mesylate for hypereosinophilic syndrome | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Imatinib Mesylate for respiratory distress syndrome | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Imatinib Mesylate for respiratory insufficiency | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |